Duopharma Biotech Berhad (KLSE: DPHARMA)
Health Care · Pharmaceuticals · MY
RM1.24
-0.80% today · -6.8% 1Y
Duopharma Biotech Berhad (KLSE: DPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $295.36M.
Over the last twelve months the share price has lost 6.8%, trading between 1.18 and 1.57.
Tweenvest scores Duopharma Biotech Berhad across four factors: quality 75/100, value 80/100, growth 76/100, dividend 81/100. Its strongest factor is dividend.
DPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $295.36M
- Revenue (TTM)
- $227.57M
- P/E
- 11.67
- EPS
- 0.11
- Dividend yield
- 3.67%
- Beta (5Y)
- 0.35
- 52-week high
- RM1.57
- 52-week low
- RM1.18
- Avg volume (3M)
- —
- Shares outstanding
- 961.94M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.16 | +0.12% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | 0.00% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.27 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.70 | -0.03% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.52 | -0.99% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.